Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00002800 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Neutropenia

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: lintuzumab
DRUG: cytarabine
DRUG: etoposide
DRUG: idarubicin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]